Canopy Growth

(NYSE: CGC)
Healthcare  |  Drug Manufacturers - Specialty & Generic
25.32 -1.02 -3.87%
Stock Price | Sept. 20, 2019, 4 p.m.
11 Followers
Bid: 0.0
Ask: 0.0
Prev. Close: 26.34
52 Week Low: 22.7601
52 Week High: 59.25
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.

Read more Read less

Recently Viewed Tickers

Premium Cannabis Stocks Review - AM Edition 09/20/19

23 Comments
16 hours ago

Premium Cannabis Stocks Review - Pre-Market Edition 09/20/19

58 Comments
Yesterday

Premium Cannabis Stocks Review - Pre-Market Edition 09/19/19

6 Comments
2 days ago

Premium Cannabis Stocks Review - Weekend Edition 09/16/19

36 Comments
6 days ago

Premium Toking Tuesday Chat - 9/10/19

10 Comments
1 week ago

Premium Cannabis Stocks Review - Weekend Edition 09/09/19

12 Comments
1 week ago

Premium Cannabis Stocks Review - Pre-Market Edition 09/06/19

29 Comments
2 weeks ago

Premium Cannabis Stocks Review - Weekend Edition 09/03/19

30 Comments
2 weeks ago

Premium Cannabis Stocks Review - Pre-Market Edition 08/28/19

3 Comments
3 weeks ago

Premium Cannabis Stocks Review - AM Edition 08/27/19

161 Comments
3 weeks ago